Cart (0)
Your shopping cart is empty!
Polyoxidonium (Azoximeri bromidum) Lyophilisate 6mg N5
Polyoxidonium (Azoximeri bromidum) Lyophilisate 6mg N5
Product Code: polyoxidonium-(azoximeri-bromidum)-lyophilisate-6mg-n5

Polyoxidonium (Azoximeri bromidum) Lyophilisate 6mg N5

Compare this Product
$44.00
13

Active substance

Azoxime bromide

Amount in a package

5

Dosage form

injection

Manufacturer

Petrovax Pharm, Russia

Composition

Composition per 1 ampoule or vial:

Active substance: Polyoxidonium® (Azoxime bromide) 3 mg or 6 mg

Excipients: mannitol, povidone, beta-carotene - up to 4.5 mg for a dosage of 3 mg or up to 9 mg for a dosage of 6 mg.

Description: porous mass from white with a yellowish tinge to yellow. The drug is hygroscopic and photosensitive.


Indications

Correction of immunity in adults and children from 6 months.

In adults in complex therapy:

• chronic relapsing infectious-inflammatory diseases, which can not be standardized in the acute and remission stage;

• acute and chronic viral and bacterial infections (including urogenital infectious-inflammatory diseases);

• tuberculosis;

• acute and chronic allergic diseases (including pollinosis, bronchial asthma, atopic dermatitis), complicated by chronic recurrent bacterial and viral infection;

• in oncology during and after chemotherapy and radiotherapy to reduce immunosuppressive, nephro- and hepatotoxic effects of drugs;

• for activation of regenerative processes (fractures, burns, trophic ulcers);

• rheumatoid arthritis, long-term treated with immunosuppressants; with complicated ARI course of rheumatoid arthritis;

• for the prevention of postoperative infectious complications;

• for the prevention of influenza and acute respiratory disease

In children in complex therapy:

• acute and chronic inflammatory diseases caused by pathogens of bacterial, viral, fungal infections (including ENT organs - sinusitis, rhinitis, adenoiditis, pharyngeal tonsillitis hypertrophy, ARVI);

• Acute allergic and toxic-allergic conditions;

• bronchial asthma, complicated by chronic infections of the respiratory tract;

• atopic dermatitis, complicated by a purulent infection;

• intestinal dysbiosis (in combination with specific therapy);

• for rehabilitation often and long-term sick;

• prevention of influenza and acute respiratory infections.